Masseter Muscle Hypertrophy Clinical Trial
Official title:
Prospective Evaluation of Xeomin Cosmetic in the Management of the Masseter Using Two Different Injection Techniques
The goal of this study was to evaluate the efficacy and safety of two injection techniques in the management of masseteric hypertrophy using Xeomin Cosmetic.
Background: Xeomin Cosmetic has been used previously in the management of masseteric
hypertrophy. However, a standardized injection technique has not been established. The goal
of the present study was to evaluate the efficacy and safety of two injection techniques in
the management of masseteric hypertrophy using Xeomin Cosmetic.
Methods: Thirty female patients with masseteric hypertrophy were recruited and evenly
randomized to receive bilateral treatments of either 1) a single injection technique (SIT),
or 2) a multi-injection technique (MIT). Improvement of masseteric hypertrophy was assessed
at Week 16 using standardized measurements and photographs. Patients completed a 5-point
satisfaction questionnaire while physicians the global aesthetic improvement scale (GAIS) and
10-point photonumeric masseter prominence rating scale.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06408766 -
Investigating the Effects of Smartphone Use on the Masseter Muscle
|
||
| Completed |
NCT02010775 -
Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle Hypertrophy
|
Phase 2 | |
| Recruiting |
NCT06343194 -
Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism
|
N/A | |
| Completed |
NCT03452345 -
MEDITOXIN® Treatment in Subject With Benign Masseteric Hypertrophy
|
Phase 3 |